{
    "data": {
    "evidenceItems": {
    "totalCount": 192,
    "pageInfo": {
        "endCursor": "NQ",
        "hasNextPage": true
        },
        "nodes": [
        {
        "id": 7313,
        "variant": {
        "name": "Mutation"
        },
        "gene": {
        "name": "PIK3CA"
        },
        "evidenceLevel": "A",
        "evidenceRating": 5,
        "disease": {
        "name": "Breast Cancer"
        },
        "drugs": [
        {
        "name": "Alpelisib"
        },
        {
        "name": "Fulvestrant"
    }
    ],
    "source": {
    "sourceType": "PUBMED"
    }
    },
    {
    "id": 1113,
    "variant": {
    "name": "Amplification"
    },
    "gene": {
    "name": "ERBB2"
    },
    "evidenceLevel": "A",
    "evidenceRating": 4,
    "disease": {
    "name": "Her2-receptor Positive Breast Cancer"
    },
    "drugs": [
    {
    "name": "Neratinib"
    },
    {
        "name": "Trastuzumab"
}
],
"source": {
"sourceType": "PUBMED"
}
},
{
"id": 1122,
"variant": {
"name": "Amplification"
},
"gene": {
"name": "ERBB2"
},
"evidenceLevel": "A",
"evidenceRating": 4,
"disease": {
"name": "Her2-receptor Positive Breast Cancer"
},
"drugs": [
{
"name": "Trastuzumab"
}
],
"source": {
"sourceType": "PUBMED"
}
},
{
"id": 7315,
"variant": {
"name": "E542K"
},
"gene": {
"name": "PIK3CA"
},
"evidenceLevel": "A",
"evidenceRating": 3,
"disease": {
"id": 22,
"name": "Breast Cancer"
},
"drugs": [
{
"name": "Alpelisib"
},
{
    "name": "Fulvestrant"
}
],
"source": {
"sourceType": "PUBMED"
}
},
{
"id": 528,
"variant": {
"name": "Amplification"
},
"gene": {
"name": "ERBB2"
},
"evidenceLevel": "B",
"evidenceRating": 5,
"disease": {
"name": "Her2-receptor Positive Breast Cancer"
},
"drugs": [
{
"name": "Trastuzumab"
}
],
"source": {
"sourceType": "PUBMED"
}
}
]
}
}
}